- Home
- NATH vs MRVI Comparison
NATH vs MRVI Comparison
Compare NATH & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- MRVI
- Stock Information
- Founded
- NATH 1916
- MRVI 2014
- Country
- NATH United States
- MRVI United States
- Employees
- NATH N/A
- MRVI N/A
- Industry
- NATH Restaurants
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- MRVI Health Care
- Exchange
- NATH Nasdaq
- MRVI Nasdaq
- Market Cap
- NATH 385.4M
- MRVI 312.4M
- IPO Year
- NATH N/A
- MRVI 2020
- Fundamental
- Price
- NATH $103.46
- MRVI $2.20
- Analyst Decision
- NATH
- MRVI Hold
- Analyst Count
- NATH 0
- MRVI 10
- Target Price
- NATH N/A
- MRVI $6.84
- AVG Volume (30 Days)
- NATH 19.1K
- MRVI 1.9M
- Earning Date
- NATH 06-11-2025
- MRVI 05-12-2025
- Dividend Yield
- NATH 1.92%
- MRVI N/A
- EPS Growth
- NATH 24.88
- MRVI N/A
- EPS
- NATH 5.80
- MRVI N/A
- Revenue
- NATH $146,386,000.00
- MRVI $241,856,000.00
- Revenue This Year
- NATH N/A
- MRVI N/A
- Revenue Next Year
- NATH N/A
- MRVI $11.28
- P/E Ratio
- NATH $18.44
- MRVI N/A
- Revenue Growth
- NATH 6.83
- MRVI N/A
- 52 Week Low
- NATH $66.35
- MRVI $1.67
- 52 Week High
- NATH $107.00
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- NATH 57.38
- MRVI 49.34
- Support Level
- NATH $100.90
- MRVI $2.20
- Resistance Level
- NATH $107.00
- MRVI $2.41
- Average True Range (ATR)
- NATH 2.91
- MRVI 0.14
- MACD
- NATH -0.06
- MRVI 0.00
- Stochastic Oscillator
- NATH 61.87
- MRVI 44.09
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.